A Patient with Cardiac Sarcoidosis in Whom an Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxyglucose and Sustained Ventricular Tachycardia Recurred 3.5 Years after Discontinuing Oral Corticosteroid Therapy
-
- Fujita Shuichi
- Department of Cardiology, Osaka Medical College, Japan
-
- Terasaki Fumio
- Department of Cardiology, Osaka Medical College, Japan Medical Education Center, Osaka Medical College, Japan
-
- Miyamura Masatoshi
- Department of Cardiology, Osaka Medical College, Japan
-
- Kanzaki Yumiko
- Department of Cardiology, Osaka Medical College, Japan
-
- Inoue Masanao
- Department of Cardiology, Osaka Medical College, Japan
-
- Fujiyoshi Hideki
- Department of Cardiology, Osaka Medical College, Japan
-
- Morimoto Tomoshige
- Department of Cardiovascular Surgery, Osaka Medical College, Japan
-
- Hoshiga Masaaki
- Department of Cardiology, Osaka Medical College, Japan
この論文をさがす
抄録
<p>We herein report a woman diagnosed with cardiac sarcoidosis (CS) based on the presence of epithelioid granulomas in non-cardiac organs and clinical findings including sustained ventricular tachycardia (VT) and cardiac dysfunction. She stopped oral corticosteroid after 4 years of treatment, and an abnormal myocardial uptake of fluorine-18 fluorodeoxyglucose and sustained VT recurred 3.5 years later. There is no consensus concerning whether or not corticosteroid therapy should be discontinued in the treatment of CS. As a relapse of sarcoidosis-related inflammation may be associated with life-threatening arrhythmia, some patients should continue corticosteroid therapy, even at low doses. </p>
収録刊行物
-
- Internal Medicine
-
Internal Medicine 59 (18), 2275-2280, 2020-09-15
一般社団法人 日本内科学会